Healthcare - Biotechnology - NASDAQ - US
$ 28.39
-6.33 %
$ 2.85 B
Market Cap
-7.93
P/E
Price Target
Average
64.23%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
19.02%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Dyne Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for DYN of $46.6 , with forecasts ranging from a low of $40 to a high of $55 .
DYN Lowest Price Target
Wall Street Target
40 USD
40.89%
DYN Average Price Target
Wall Street Target
46.6 USD
64.23%
DYN Highest Price Target
Wall Street Target
55 USD
93.73%
REVENUE FORECAST
Revenue Forecast Chart DYN
EBIT FORECAST
EBIT Forecast Chart DYN
NET INCOME FORECAST
Net Income Chart DYN